ES2430394T3 - Uso de agentes biológicos parasitarios para la prevención y el control de la enfermedad inflamatoria intestinal - Google Patents

Uso de agentes biológicos parasitarios para la prevención y el control de la enfermedad inflamatoria intestinal Download PDF

Info

Publication number
ES2430394T3
ES2430394T3 ES06021312T ES06021312T ES2430394T3 ES 2430394 T3 ES2430394 T3 ES 2430394T3 ES 06021312 T ES06021312 T ES 06021312T ES 06021312 T ES06021312 T ES 06021312T ES 2430394 T3 ES2430394 T3 ES 2430394T3
Authority
ES
Spain
Prior art keywords
parasite
parasites
eggs
cells
mice
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES06021312T
Other languages
English (en)
Spanish (es)
Inventor
Joel Weinstock
David E. Elliott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Iowa Research Foundation UIRF
Original Assignee
University of Iowa Research Foundation UIRF
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Iowa Research Foundation UIRF filed Critical University of Iowa Research Foundation UIRF
Application granted granted Critical
Publication of ES2430394T3 publication Critical patent/ES2430394T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES06021312T 1997-12-31 1998-12-11 Uso de agentes biológicos parasitarios para la prevención y el control de la enfermedad inflamatoria intestinal Expired - Lifetime ES2430394T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7014797P 1997-12-31 1997-12-31
US70147P 1997-12-31

Publications (1)

Publication Number Publication Date
ES2430394T3 true ES2430394T3 (es) 2013-11-20

Family

ID=22093437

Family Applications (1)

Application Number Title Priority Date Filing Date
ES06021312T Expired - Lifetime ES2430394T3 (es) 1997-12-31 1998-12-11 Uso de agentes biológicos parasitarios para la prevención y el control de la enfermedad inflamatoria intestinal

Country Status (10)

Country Link
US (3) US6764838B2 (ja)
EP (3) EP1041994A4 (ja)
JP (3) JP4733830B2 (ja)
AU (1) AU740776B2 (ja)
CA (1) CA2315790C (ja)
DK (1) DK1749534T3 (ja)
ES (1) ES2430394T3 (ja)
HK (1) HK1100745A1 (ja)
PT (1) PT1749534E (ja)
WO (1) WO1999033479A1 (ja)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2315790C (en) * 1997-12-31 2015-10-06 University Of Iowa Research Foundation Use of parasitic biological agents for prevention and control of autoimmune diseases
GB9824034D0 (en) * 1998-11-03 1998-12-30 Univ Nottingham Immunomodulatory factors forimmunosuppressant and antiallergic treatment
US20050118655A1 (en) * 2003-11-17 2005-06-02 University Of Iowa Research Foundation Use of parasitic biological agents for diseases prevention and control
US20060024333A1 (en) * 2004-07-26 2006-02-02 O'connor Daniel J Use of parasitic biological agents for prevention and control of allergic and other IgE-mediated disorders
JP5689585B2 (ja) * 2005-12-30 2015-03-25 パラサイト テクノロジーズ エーエスＰａｒａｓｉｔｅ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ａ／Ｓ 寄生虫卵を含む組成物および寄生虫卵を分離および保存する方法
DE102006023906A1 (de) * 2006-05-19 2007-11-22 Ovamed Gmbh Verfahren zum Nachweis der Viabilität
US20090202517A1 (en) * 2006-08-17 2009-08-13 Hiroyuki Yoneyama Agents for improving inflammatory bowel disease
GB2447884B (en) * 2007-03-02 2011-10-26 Mark Barnett Treatment for skin disease
EP1977643A1 (de) * 2007-04-02 2008-10-08 Dr. Falk Pharma Gmbh Herstellung einer viablen, lagerfähigen Wurmeiersuspension
US20100260861A1 (en) * 2007-04-10 2010-10-14 Joel Weinstock Treatments with helminths
EP2123774A1 (de) 2008-05-21 2009-11-25 Dr. Falk Pharma Gmbh Verfahren zur Charakterisierung der biologischen Aktivität von Helminth-Eiern
US20100124574A1 (en) * 2008-06-19 2010-05-20 Parasite Technologies A/S Composition Comprising Parasite Eggs And Methods For Isolation And Storage Of Parasite Eggs
JP5935200B2 (ja) * 2010-10-27 2016-06-15 国立大学法人山口大学 蠕虫性寄生生物由来の免疫賦活剤
WO2012137899A1 (ja) * 2011-04-06 2012-10-11 学校法人麻布獣医学園 2型糖尿病の発症を抑制する寄生虫
RU2486238C1 (ru) * 2011-12-29 2013-06-27 Государственное бюджетное образовательное учреждение высшего профессионального образования "Сибирский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации (ГБОУ ВПО СибГМУ Минздравсоцразвития России) СПОСОБ НАГРУЗКИ ДЕНДРИТНЫХ КЛЕТОК АНТИГЕНОМ ИНФЕКЦИОННОГО ПРОИСХОЖДЕНИЯ Opisthorchis felineus
US9224200B2 (en) 2012-04-27 2015-12-29 Parasite Technologies A/S Computer vision based method for extracting features relating to the developmental stages of Trichuris spp. eggs
WO2014151648A1 (en) * 2013-03-15 2014-09-25 Coronado Biosciences, Inc. Treatment of autoimmune disease using helminthic parasites
GB201402909D0 (en) * 2014-02-19 2014-04-02 Univ Southampton Treating infection
US9603875B1 (en) 2016-01-07 2017-03-28 NeuOva, LLC Method of making a consumable product with purified embryonated Trichuris suis ova
FR3069163B1 (fr) * 2017-07-21 2020-07-10 Fondation Mediterranee Infection Extrait aqueux d'un broyat de planaires
EP3801579A1 (en) * 2018-06-04 2021-04-14 Aarhus Universitet Worm products and methods of use
KR102270850B1 (ko) * 2019-11-25 2021-06-28 전남대학교산학협력단 관절염 예방 또는 치료용 약학 조성물
KR102643035B1 (ko) * 2021-05-24 2024-02-29 전남대학교산학협력단 관절염 예방 또는 치료용 약학 조성물

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4158049A (en) * 1976-09-27 1979-06-12 Edna Mcconnell Clark Foundation Antigen fraction of Schistosoma mansoni eggs suitable for testing for schistosomiasis
US4314992A (en) * 1978-11-08 1982-02-09 Bitakaramire Peter K Process for producing fascioliasis vaccine
US4396600A (en) * 1980-12-18 1983-08-02 Gus Gallucci Adult schistosome worm-derived antigenic substance and method of obtaining same
WO1996040717A1 (en) * 1995-06-07 1996-12-19 Nexstar Pharmaceuticals, Inc. High-affinity nucleic acid ligands of cytokines
JP2700088B2 (ja) * 1991-07-25 1998-01-19 房則 濱島 免疫抑制剤
DE69331018T2 (de) * 1992-05-11 2002-06-13 Corvas International, Inc. Neutrophilen inhibitoren aus nematoden
WO1995024425A1 (en) * 1994-03-11 1995-09-14 Board Of Regents, The University Of Texas System Immunomodulatory trichinella substances
US6066322A (en) * 1995-03-03 2000-05-23 Millennium Pharmaceuticals, Inc. Methods for the treatment of immune disorders
AU5344996A (en) * 1995-03-23 1996-10-08 Governors Of Dalhousie College And University A process of prolonging organ allograft survival
US5882943A (en) * 1996-07-31 1999-03-16 Aldeen; William Erick Filtration apparatus, kit and method for processing parasite samples
CA2315790C (en) * 1997-12-31 2015-10-06 University Of Iowa Research Foundation Use of parasitic biological agents for prevention and control of autoimmune diseases
GB9824034D0 (en) * 1998-11-03 1998-12-30 Univ Nottingham Immunomodulatory factors forimmunosuppressant and antiallergic treatment
DE10109844A1 (de) * 2001-03-01 2003-02-27 Forschungszentrum Borstel Zent Immunmodulierende Wirkstoffe aus parasitären Würmern und Verfahren zu deren Isolierung
JP2003132677A (ja) * 2001-10-29 2003-05-09 Mitsubishi Electric Corp 半導体記憶装置
US20050118655A1 (en) * 2003-11-17 2005-06-02 University Of Iowa Research Foundation Use of parasitic biological agents for diseases prevention and control
US20060024333A1 (en) * 2004-07-26 2006-02-02 O'connor Daniel J Use of parasitic biological agents for prevention and control of allergic and other IgE-mediated disorders
JP5689585B2 (ja) * 2005-12-30 2015-03-25 パラサイト テクノロジーズ エーエスＰａｒａｓｉｔｅ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ａ／Ｓ 寄生虫卵を含む組成物および寄生虫卵を分離および保存する方法
US20100124574A1 (en) * 2008-06-19 2010-05-20 Parasite Technologies A/S Composition Comprising Parasite Eggs And Methods For Isolation And Storage Of Parasite Eggs

Also Published As

Publication number Publication date
US7250173B2 (en) 2007-07-31
EP1041994A1 (en) 2000-10-11
JP4733830B2 (ja) 2011-07-27
US6764838B2 (en) 2004-07-20
EP1749534A2 (en) 2007-02-07
US20070298011A1 (en) 2007-12-27
EP1749534A3 (en) 2007-02-21
US20040202671A1 (en) 2004-10-14
CA2315790C (en) 2015-10-06
EP1749534B1 (en) 2013-08-21
EP1041994A4 (en) 2003-02-19
JP2011016840A (ja) 2011-01-27
WO1999033479A1 (en) 1999-07-08
EP2255820A1 (en) 2010-12-01
JP2014129390A (ja) 2014-07-10
PT1749534E (pt) 2013-09-13
HK1100745A1 (en) 2007-09-28
AU1821399A (en) 1999-07-19
DK1749534T3 (da) 2013-09-02
JP2001527048A (ja) 2001-12-25
CA2315790A1 (en) 1999-07-08
US20030039666A1 (en) 2003-02-27
US7833537B2 (en) 2010-11-16
AU740776B2 (en) 2001-11-15

Similar Documents

Publication Publication Date Title
ES2430394T3 (es) Uso de agentes biológicos parasitarios para la prevención y el control de la enfermedad inflamatoria intestinal
KR101363138B1 (ko) 질병 예방과 통제를 위한 기생충 생물제의 용도
US9192633B2 (en) Use of parasitic biological agents for disease prevention and control
Kigoni et al. IgE antibody and resistance to infection II. Effect of IgE suppression on the early and late skin reaction and resistance of rats to Schistosoma mansoni infection
US9730988B2 (en) Parasitic biological agents for treatment and prevention of graft versus host disease
WO2013039872A1 (en) Compositions and methods for treating inflammatory bowel diseases
Katz Anthelmintics: current concepts in the treatment of helminthic infections
Singaravelu et al. Nematode larva migrans
Richardson Other noteworthy zoonotic helminths
Maruyama et al. 18. Immunology of Nematode Infection
Asaolu et al. Ascaris lumbricoides (Ascariasis)
Blum Induction Of The Intestinal Th2 Immune Response To The Parasitic Nematode Trichinella Spiralis: Rapid Expulsion, Distinct Regional Immunity, And The Role Of Innate Mediators.
Weinstock et al. The Influence of Helminths on Immunological Diseases